Delivery Order 36F79725D0093-36C25026N0655
Award Date 7/15/26
Potential Completion Date 7/14/27
Potential Value $722K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bedford, MA 01730, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 7 issued a delivery order to Progenics Pharmaceuticals Inc. on November 1, 2023, for 80 units of PYLARIFY (piflufolastat F-18), a radiopharmaceutical diagnostic imaging agent, with a ceiling value of $3,210,152.08 and firm fixed-price terms. The order is issued under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is North Billerica, Billerica, MA. The ultimate completion date is October 31, 2028. PYLARIFY is a...
- Veterans Integrated Service Network 12 issued a $2,959,150.40 delivery order to Progenics Pharmaceuticals Inc. on May 1, 2026, for PYLARIFY (piflufolastat F-18) prostate imaging radiopharmaceuticals under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed-price with no set-aside designation and extends through April 30, 2030. Place of performance is Bedford, MA. PYLARIFY is a radioactive diagnostic imaging agent used in positron emission tomography scans...
- Veterans Integrated Service Network 12 issued a $4.77 million firm fixed-price delivery order to Progenics Pharmaceuticals Inc. on May 1, 2025, for supply of PYLARIFY (piflufolastat F-18) radiopharmaceutical with a base period plus three one-year option years and ultimate completion date of April 30, 2026. The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a GSA-administered multiple-award vehicle. Place of performance is Bedford, MA. PYLARIFY is a...
- Veterans Integrated Service Network 20 issued a $469,133.60 delivery order to Progenics Pharmaceuticals Inc. on July 1, 2026, for PYLARIFY (piflufolastat F-18) injections, a radiopharmaceutical diagnostic imaging agent used in positron emission tomography scans for prostate cancer detection. This delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), the GSA-administered master contract vehicle for pharmaceutical procurement across federal agencies....
- Veterans Integrated Service Network 7 issued a delivery order to Progenics Pharmaceuticals Inc. on May 1, 2022, with a ceiling value of $5,719,999.20 for supply of PYLARIFY (fluorine 18 piflufolastat), a radiopharmaceutical diagnostic imaging agent used in positron emission tomography scans for prostate cancer detection in veterans. The delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a GSA-administered master contract vehicle supporting federal...
- Veterans Integrated Service Network 22 issued a delivery order to Progenics Pharmaceuticals Inc. on September 1, 2025, with a ceiling value of $997,180.56 under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical diagnostic imaging agent for positron emission tomography scans. The order is firm fixed price with ultimate completion by August 31, 2026. Place of performance is North Billerica, Billerica, MA....
- Progenics Pharmaceuticals Inc., operating as a division of Lantheus Medical Imaging, Inc., was awarded a $558,691.12 firm fixed-price delivery order by Veterans Integrated Service Network 10 on May 1, 2026, for the supply of F-18 PYLARIFY (piflufolastat F-18) radiopharmaceutical products. The contract, which carries no set-aside designation, is scheduled for completion by December 31, 2026, with performance occurring at the contractor's facility in North Billerica, Massachusetts. This delivery...
- The Department of Veterans Affairs, Veterans Integrated Service Network 12 (VISN 12) awarded a delivery order contract to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging Inc., for the supply of PYLARIFY (piflufolastat F-18) radiopharmaceutical products. This contract, valued at $1,000,789.28 on a firm fixed-price basis with no set-aside designation, is scheduled for completion by August 31, 2025. PYLARIFY is a radioactive diagnostic imaging agent used in positron...
- Progenics Pharmaceuticals Inc., operating as a division of Lantheus Medical Imaging, Inc., was awarded a $599,047.52 firm fixed-price delivery order by Veterans Integrated Service Network 5 on February 1, 2026, for PYLARIFY (piflufolastat F-18) injection radiopharmaceuticals. The contract, with an ultimate completion date of March 1, 2026, contains no set-aside designation and represents performance at the company's facility in Bedford, Massachusetts. This delivery order falls under the...
- Progenics Pharmaceuticals Inc., operating as a division of Lantheus Medical Imaging Inc., was awarded a delivery order valued at $260,227.84 by Veterans Integrated Service Network 15 on October 22, 2024, for the supply of PYLARIFY (piflufolastat F-18) radiopharmaceutical injections. This firm fixed-price delivery order carries no set-aside designation and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract. The contract is scheduled for ultimate...